We conclude that sgc8c‐TDN is a feasible targeted drug delivery system and that s‐TDN:DOX may serve as an ideal targeted treatment against ALL or other PTK7‐positive tumours. The gene discussed is PTK7; the disease is acute lymphoblastic leukemia.